相关实验视频

Updated: Jun 9, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

新型抗Trop2纳米体破坏受体二分化并抑制瘤细胞生长

Junwen Deng^1,2, Zhongmin Geng^1,2, Linli Luan³

¹The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266071, China.

|October 26, 2024

概括

开发了两种新型纳米体N14和N152,以向Trop2 (质细胞表面抗原2),这是许多癌症中过度表达的蛋白质. 这些纳米体破坏Trop2二分化,并显示出显著的抗瘤疗效,提供了一个有前途的新疗法方法.

科学领域:

生物化学生物化学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

热囊细胞表面抗原2 (Trop2) 是一个有前途的泛癌治疗点,因为它在多种恶性瘤中过度表达,并与预后不佳相关.
目前的Trop2向疗法,如抗体药物合物 (ADC),面临诸如副作用,耐药性和有效性有限等挑战.
Trop2的二元形式对瘤功能至关重要,现有的药物表位离二元化接口很远,可能会阻碍疗效.

研究的目的:

识别和描述针对Trop2的新型纳米体.
研究这些纳米体在破坏Trop2二分化和抑制瘤生长方面的潜力.
阐明新发现的Trop2向纳米体的独特结合模式和作用机制.

主要方法:

合成纳米体库对Trop2细胞外域 (Trop2-ECD) 的选.
纳米体结合特异性,亲和力和生物活性的表征,包括抗原-抗体内细胞和细胞增殖抑制.
使用ELISA和使用AlphaFold 3进行预测建模以确定结合部位和机制.

主要成果:

确定了两个高亲和度,特定的纳米体,N14和N152.
N14和N152在Trop2-阳性瘤细胞中表现出有效的Trop2内化和抑制增殖.
皮层映射显示,N14和N152与所有Trop2-ECD子域结合,并破坏Trop2二分化,可能针对cis-二分化接口.

结论:

新型纳米体N14和N152特别与Trop2结合,具有独特的表位位向.
这些纳米体通过破坏Trop2二分化,表现出显著的抗瘤功效.
N14和N152代表了创新的Trop2向疗法,有可能改善胰腺癌治疗结果.

关键词:

反Trop2的纳米体.抗瘤功效抗瘤功效标志性表现物 (Epitopes) 是一种表现物.

更多相关视频

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Receptor Tyrosine Kinases

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...